Literature DB >> 19429477

Epigenetic alterations in cervical carcinogenesis.

Anita Szalmás1, József Kónya.   

Abstract

During cervical carcinogenesis, the major etiologic factor, the persistent oncogenic HPV infection itself is not sufficient to immortalize and transform the epithelial host cells. Together with further genetic and epigenetic alterations disrupting the cell cycle control, the host cell acquires immortal phenotype and progresses further to an overt malignant and invasive phenotype. Here, we discuss how cancer-associated epigenetic alterations can affect the expression of papillomaviral as well as host genes in relation to stages representing the multistep process of carcinogenesis. Biomarker roles in clinical diagnosis and prognosis might be assigned to the epigenetic pattern of the involved genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429477     DOI: 10.1016/j.semcancer.2009.02.011

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  41 in total

1.  Epigenetics of human papillomaviruses.

Authors:  Eric Johannsen; Paul F Lambert
Journal:  Virology       Date:  2013-08-13       Impact factor: 3.616

2.  Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Authors:  Denise M Schütze; Jan M Kooter; Saskia M Wilting; Chris J L M Meijer; Wim Quint; Peter J F Snijders; Renske D M Steenbergen
Journal:  Epigenetics       Date:  2015-01-23       Impact factor: 4.528

Review 3.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

Review 4.  Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.

Authors:  Renske D M Steenbergen; Peter J F Snijders; Daniëlle A M Heideman; Chris J L M Meijer
Journal:  Nat Rev Cancer       Date:  2014-06       Impact factor: 60.716

5.  WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.

Authors:  Amber L Delmas; Bridget M Riggs; Carolina E Pardo; Lisa M Dyer; Russell P Darst; Eugene G Izumchenko; Mänette Monroe; Ardeshir Hakam; Michael P Kladde; Erin M Siegel; Kevin D Brown
Journal:  Carcinogenesis       Date:  2011-08-26       Impact factor: 4.944

6.  CpG methylation in human papillomavirus (HPV) type 31 long control region (LCR) in cervical infections associated with cytological abnormalities.

Authors:  Brigitta László; Annamária Ferenczi; László Madar; Eszter Gyöngyösi; Anita Szalmás; Levente Szakács; György Veress; József Kónya
Journal:  Virus Genes       Date:  2016-04-20       Impact factor: 2.332

7.  Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes.

Authors:  Yan Chen Wongworawat; Maria Filippova; Vonetta M Williams; Valery Filippov; Penelope J Duerksen-Hughes
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

8.  Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer.

Authors:  Chel Hun Choi; Joon-Yong Chung; Hanbyoul Cho; Haruhisa Kitano; Eileen Chang; Kris Ylaya; Eun Joo Chung; Jae-Hoon Kim; Stephen M Hewitt
Journal:  Pathobiology       Date:  2015-08-25       Impact factor: 4.342

9.  Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection.

Authors:  Huan Lu; Peng-Cheng Jiang; Xiao-Dan Zhang; Wen-Jing Hou; Zhen-Hong Wei; Jia-Qi Lu; Hao Zhang; Guang-Xu Xu; Yuan-Ping Chen; Yuan Ren; Li Wang; Rong Zhang; Ying Han
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 10.  DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.

Authors:  Sandra Mersakova; Marcela Nachajova; Peter Szepe; Petra Sumichrastova Kasajova; Erika Halasova
Journal:  Tumour Biol       Date:  2015-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.